Quanterix Corporation Increase (Decrease) in Other Noncurrent Liabilities
Quanterix Corporation (QTRX) reported Increase (Decrease) in Other Noncurrent Liabilities of -$3.68 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-10
- Quanterix Corporation increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was -$1.94M, a 2556.96% decline year-over-year.
- Quanterix Corporation increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was -$1.74M.
- Quanterix Corporation increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $3.34M.
- Quanterix Corporation increase (decrease) in other noncurrent liabilities for the quarter ending 2025-06-30 was $79.00K, a 172.41% increase year-over-year.
- Quanterix Corporation increase (decrease) in other noncurrent liabilities for fiscal 2024 was $3.00K.
- Quanterix Corporation increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$53.00K, a 630.00% decline from fiscal 2022.
- Quanterix Corporation increase (decrease) in other noncurrent liabilities for fiscal 2022 was $10.00K.
- Quanterix Corporation increase (decrease) in other noncurrent liabilities for fiscal 2021 was -$363.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 3 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month as first filed | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$3.68M 10-Q · filed 2026-08-10 | ||||
| 2026-03-31 | -$1.74M 10-Q · filed 2026-05-06 | |||||
| 2025-09-30 | $3.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $3.42M derived: sum of 2 quarters · filed 2026-08-10 | -$1.23M 10-Q · filed 2025-11-10 | -$1.24M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$4.57M 10-Q · filed 2026-08-10 | -$2.37M 10-Q · filed 2025-08-07 | -$4.58M derived: sum of 3 quarters · filed 2026-08-10 | -$4.61M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | -$4.65M 10-Q · filed 2026-05-06 | -$2.99M 10-Q · filed 2025-05-12 | -$4.66M derived: sum of 2 quarters · filed 2026-05-06 | -$4.69M derived: sum of 3 quarters · filed 2026-05-06 | -$4.66M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$36.00K derived: sum of 2 quarters · filed 2025-11-10 | -$7.00K derived: sum of 3 quarters · filed 2025-11-10 | $3.00K 10-K · filed 2025-03-17 | ||
| 2024-09-30 | -$28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.00K derived: sum of 2 quarters · filed 2025-11-10 | $11.00K 10-Q · filed 2025-11-10 | $65.00K derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $39.00K 10-Q · filed 2025-08-07 | $93.00K derived: sum of 3 quarters · filed 2025-08-07 | $58.00K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $10.00K 10-Q · filed 2025-05-12 | $64.00K derived: sum of 2 quarters · filed 2025-05-12 | $29.00K derived: sum of 3 quarters · filed 2025-05-12 | $160.00K derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $54.00K derived: 10-K 12 month − 10-K/A 9 month · filed 2025-03-17 | $19.00K derived: sum of 2 quarters · filed 2025-03-17 | $150.00K derived: sum of 3 quarters · filed 2025-03-17 | -$53.00K 10-K · filed 2025-03-17 | ||
| 2023-09-30 | -$35.00K derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26 | $96.00K derived: sum of 2 quarters · filed 2024-12-26 | -$107.00K 10-K/A · filed 2024-12-26 | -$225.00K derived: sum of 4 quarters · filed 2025-03-17 | ||
| 2023-06-30 | $131.00K derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26 | -$72.00K 10-K/A · filed 2024-12-26 | -$190.00K derived: sum of 3 quarters · filed 2025-03-17 | -$53.00K derived: sum of 4 quarters · filed 2025-03-17 | ||
| 2023-03-31 | -$203.00K 10-K/A · filed 2024-12-26 | -$321.00K derived: sum of 2 quarters · filed 2025-03-17 | -$184.00K derived: sum of 3 quarters · filed 2025-03-17 | $78.00K derived: sum of 4 quarters · filed 2025-03-17 | ||
| 2022-12-31 | -$118.00K derived: 10-K 12 month − 10-K/A 9 month · filed 2025-03-17 | $19.00K derived: sum of 2 quarters · filed 2025-03-17 | $281.00K derived: sum of 3 quarters · filed 2025-03-17 | $10.00K 10-K · filed 2025-03-17 | ||
| 2022-09-30 | $137.00K derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-12-26 | $399.00K derived: sum of 2 quarters · filed 2024-12-26 | $128.00K 10-K/A · filed 2024-12-26 | -$127.00K derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-06-30 | $262.00K derived: 10-K/A 6 month − 10-K/A 3 month · filed 2024-12-26 | -$9.00K 10-K/A · filed 2024-12-26 | -$264.00K derived: sum of 3 quarters · filed 2024-12-26 | -$252.00K derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-03-31 | -$271.00K 10-K/A · filed 2024-12-26 | -$526.00K derived: sum of 2 quarters · filed 2024-12-26 | -$514.00K derived: sum of 3 quarters · filed 2024-12-26 | -$527.00K derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2021-12-31 | -$255.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | -$243.00K derived: sum of 2 quarters · filed 2024-12-26 | -$256.00K derived: sum of 3 quarters · filed 2024-12-26 | -$363.00K 10-K/A · filed 2024-12-26 | ||
| 2021-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.00K derived: sum of 2 quarters · filed 2022-11-09 | -$108.00K 10-Q · filed 2022-11-09 | -$419.00K derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2021-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$120.00K 10-Q · filed 2022-08-08 | -$431.00K derived: sum of 3 quarters · filed 2023-03-06 | -$171.00K derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2021-03-31 | -$107.00K 10-Q · filed 2022-05-10 | -$418.00K derived: sum of 2 quarters · filed 2023-03-06 | -$158.00K derived: sum of 3 quarters · filed 2023-03-06 | -$418.00K derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2020-12-31 | -$311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$51.00K derived: sum of 2 quarters · filed 2023-03-06 | -$311.00K derived: sum of 3 quarters · filed 2023-03-06 | -$488.00K 10-K · filed 2023-03-06 | ||
| 2020-09-30 | $260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | -$177.00K 10-Q · filed 2021-11-04 | -$400.00K derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$437.00K 10-Q · filed 2020-08-04 | -$660.00K derived: sum of 3 quarters · filed 2022-03-01 | -$40.00K derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | -$177.00K 10-Q · filed 2021-05-06 | -$400.00K derived: sum of 2 quarters · filed 2022-03-01 | $220.00K derived: sum of 3 quarters · filed 2022-03-01 | $3.59M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | -$223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $397.00K derived: sum of 2 quarters · filed 2022-03-01 | $3.76M derived: sum of 3 quarters · filed 2022-03-01 | $9.85M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $620.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $3.99M derived: sum of 2 quarters · filed 2020-11-06 | $10.07M 10-Q · filed 2020-11-06 | |||
| 2019-06-30 | $3.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $9.45M 10-Q · filed 2020-08-04 | ||||
| 2019-03-31 | $6.08M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |